Most Read Articles
Audrey Abella, 21 Jul 2017
Deficiency in vitamin A (<200 µg/L) may predict the risk of incident tuberculosis (TB) in individuals with household exposure to a person with TB, a recent study has found.
14 Mar 2016
Delamanid may be a potent treatment regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) patients, based on a study.
Pearl Toh, 22 Jun 2017
The next-generation ALK inhibitor brigatinib yielded high and durable responses in both whole-body and intracranial endpoints, with a median progression-free survival (PFS) of over 1 year in patients with ALK-positive non-small cell lung cancer (NSCLC) whose disease had progressed after crizotinib, according to the ALTA* trial.
Dr Joslyn Ngu, 16 Oct 2017

The main goal of the National Strategic Plan (NSP) for TB Control (2016 to 2020) is to reduce tuberculosis (TB) burden by ensuring universal access to timely and quality diagnosis and treatment of all types of TB, and preventing the development of drug resistant TB, says an expert. 

Cross-linked N-telopeptide of type I collagen predicts bone metastasis in lung cancer

5 days ago

Elevated levels of cross-linked N-telopeptide of type I collagen (NTx) appear to raise the risk of development and progression of bone metastasis (BM) in lung cancer patients, a recent study reveals.

The research team performed a meta-analysis of 11 studies (n=1,108) that compared the expression levels of NTx between lung cancer patients with and without BM. Aside from a review of study references, the databases of Web of Science, CNKI, Wangfang, PubMed and Embase were accessed for the present study.

Pooled findings from eight studies showed that patients positive for BM had significantly higher serum NTx concentrations than their BM-negative counterparts (weighted mean difference [WMD], -11.57 percent; 95 percent CI, -15.14 to -8.00).

Similarly, urinary levels of NTx, investigated in three studies, were also found to be significantly higher in patients with BM than those without (WMD, -65.15 percent; -88.33 to -41.97).

The pooled sensitivity and specificity of serum NTx in discerning BM from non-BM lung cancer patients were 0.74 (0.67 to 0.79) and 0.85 (0.80 to 0.89), respectively. In comparison, the corresponding values for urinary NTx were 0.77 (0.67 to 0.86) and 0.81 (0.76 to 0.86).

Both serum and urinary NTx had similar and good diagnostic accuracy, with respective diagnostic odds ratios of 15.07 (9.6 to 23.65) and 15.25 (8.38 to 27.73). The respective areas under the receiver operating curve for both were 0.8889 and 0.8655, which suggests that both samples could accurately distinguish between patients with and without BM.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Audrey Abella, 21 Jul 2017
Deficiency in vitamin A (<200 µg/L) may predict the risk of incident tuberculosis (TB) in individuals with household exposure to a person with TB, a recent study has found.
14 Mar 2016
Delamanid may be a potent treatment regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) patients, based on a study.
Pearl Toh, 22 Jun 2017
The next-generation ALK inhibitor brigatinib yielded high and durable responses in both whole-body and intracranial endpoints, with a median progression-free survival (PFS) of over 1 year in patients with ALK-positive non-small cell lung cancer (NSCLC) whose disease had progressed after crizotinib, according to the ALTA* trial.
Dr Joslyn Ngu, 16 Oct 2017

The main goal of the National Strategic Plan (NSP) for TB Control (2016 to 2020) is to reduce tuberculosis (TB) burden by ensuring universal access to timely and quality diagnosis and treatment of all types of TB, and preventing the development of drug resistant TB, says an expert.